Guardant Health Breast Cancer

Listing Websites about Guardant Health Breast Cancer

Filter Type:

Tests for Cancer Screening - GuardantHealth

(3 days ago) WebExplore Guardant Health's Shield™ blood test. Discover how our advanced technology detects cancer early, when it's most treatable. INVESTORS; CAREERS; Search Approach. in metastatic breast cancer: Results from plasmaMATCH trial [abstract]. In: …

https://guardanthealth.com/products/tests-for-cancer-screening/

Category:  Cancer Show Health

What Why How When - GuardantHealth

(Just Now) WebGenetics in Breast Cancer What 1 in 8 women will develop breast cancer (men can develop breast cancer too). Why Screening and early diagnosis improves survival. How …

https://guardanthealth.com/wp-content/uploads/Cancer_Wellness_Program_Fact_Sheet_-_Breast_Cancer.pdf

Category:  Cancer Show Health

Home - GuardantHealth

(7 days ago) WebFrom using biomarkers to inform treatment in advanced cancer, to using circulating tumor DNA to not only assess response to treatment, but detect signs of remaining cancer and …

https://guardanthealth.com/

Category:  Cancer Show Health

Guardant Reveal™: First Tissue-Free MRD Test for CRC

(7 days ago) WebAnnual Physician Notice. Advance Beneficiary Notice. Technical Information. Physician Insert. Guardant Reveal™ is the first tissue-free minimal residual disease (MRD) test for …

https://www.guardantcomplete.com/products/guardant-reveal

Category:  Health Show Health

FDA clears Guardant360 as CDx for Menarini’s breast cancer drug …

(1 days ago) WebGuardant Health has received approval from the US Food and Drug Administration (FDA) to use its Guardant360 CDx liquid biopsy test as a companion …

https://www.nsmedicaldevices.com/news/fda-clears-guardant360-cdx-menarini-breast-cancer-drug-orserdu/

Category:  Food Show Health

Guardant Health to present data at San Antonio Breast Cancer …

(8 days ago) WebPALO ALTO, Calif., November 30, 2023--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, will present data showing the utility of liquid biopsy tests in …

https://finance.yahoo.com/news/guardant-health-present-data-san-130500087.html

Category:  Health Show Health

FDA Approves Blood Tests That Can Help Guide Cancer Treatment

(3 days ago) WebGuardant360 CDx, made by Guardant Health, was approved as a companion diagnostic for osimertinib (Tagrisso), a lung cancer therapy. FoundationOne …

https://www.cancer.gov/news-events/cancer-currents-blog/2020/fda-guardant-360-foundation-one-cancer-liquid-biopsy

Category:  Cancer Show Health

Guardant Health and Susan G. Komen® Partner to Develop …

(2 days ago) WebGuardant Health and Susan G. Komen® Partner to Develop Clinical Studies to Identify Early-Stage Breast Cancer Patients Who May Benefit From Additional …

https://ww.guardanthealth.com/2023/01/04/guardant-health-and-susan-g-komen-partner-to-develop-clinical-studies-to-identify-early-stage-breast-cancer-patients-who-may-benefit-from-additional-monitoring-or-therapy/

Category:  Cancer Show Health

Guardant Health, Inc. - Guardant Health Expands Use of Guardant …

(4 days ago) WebThe Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs …

https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-Expands-Use-of-Guardant-Reveal-Liquid-Biopsy-Test-for-Residual-Disease-Detection-and-Recurrence-Monitoring-to-Include-Early-Stage-Breast-and-Lung-Cancers/default.aspx

Category:  Health Show Health

Liquid Biopsy Assay Expands Offerings to Include MRD, Disease

(8 days ago) WebThe Guardant Reveal assay has been expanded for the detection of minimal residual disease (MRD) and disease recurrence in patients with early-stage breast …

https://www.onclive.com/view/liquid-biopsy-assay-expands-offerings-to-include-mrd-disease-recurrence-detection-in-early-stage-breast-and-lung-cancer

Category:  Health Show Health

Guardant Health to present real-world data supporting …

(Just Now) WebPALO ALTO, Calif., May 16, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present data from two real …

https://finance.yahoo.com/news/guardant-health-present-real-world-120500882.html

Category:  Health Show Health

The Fight Against Cancer Enters a New Phase Kiplinger

(2 days ago) WebSome are focused on one type of cancer, such as Guardant Health’s colorectal test. Others, like GRAIL’s Galleri , aim to test for multiple cancers in one go, …

https://www.kiplinger.com/business/fight-against-cancer-enters-new-phase

Category:  Cancer Show Health

Guardant Health, Inc. - Guardant Health Announces Collaboration …

(7 days ago) WebThe Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs …

https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-Announces-Collaboration-With-AstraZeneca-to-Develop-Companion-Diagnostic-to-Identify-Patients-With-ESR1-mutated-Metastatic-Breast-Cancer/default.aspx

Category:  Health Show Health

State-of-the-Art Management of Colorectal Cancer: Treatment …

(8 days ago) WebColorectal cancer (CRC) remains a significant global health challenge, ranking among the leading causes of cancer-related morbidity and mortality worldwide. …

https://ascopubs.org/doi/abs/10.1200/EDBK_438466

Category:  Cancer Show Health

Guardant Health Receives ‘Buy’ Rating on Strong Q1 Performance …

(Just Now) WebGuardant Health, Inc. is a precision oncology company, which engages in provision of precision oncology testing and development services. It focuses performing …

https://markets.businessinsider.com/news/stocks/guardant-health-receives-buy-rating-on-strong-q1-performance-and-positive-financial-outlook-1033371016

Category:  Health Show Health

ESMO Breast Cancer 2024 OncologyPRO

(5 days ago) Web5 Kanagawa Cancer Center, Yokohama/JP; 6 Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing/CN; 7 National …

https://oncologypro.esmo.org/meeting-resources/esmo-breast-cancer-2024/exploratory-pooled-safety-analysis-of-trastuzumab-deruxtecan-t-dxd-in-patients-with-her2-or-her2-low-unresectable-and-or-metastatic-breast-cance

Category:  Cancer,  Medical Show Health

Filter Type: